Your browser doesn't support javascript.
loading
Chemical-Empowered Human Adipose-Derived Stem Cells with Lower Immunogenicity and Enhanced Pro-angiogenic Ability Promote Fast Tissue Regeneration.
Yi, Junzhi; Zhang, Jiayan; Zhang, Qin; Chen, Xuri; Qi, Rujie; Liang, Renjie; Wang, Ying; Wang, Fei; Zhong, Yuliang; Zhang, Xianzhu; Chin, Grace; Liu, Qi; Zhou, Wenyan; Liu, Hua; Chen, Jiansong; Ouyang, Hongwei.
Affiliation
  • Yi J; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, and Department of Orthopedic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhang J; Department of Sports Medicine, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhang Q; Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, and Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Chen X; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, and Department of Orthopedic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Qi R; Department of Sports Medicine, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Liang R; Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, and Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Wang Y; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, and Department of Orthopedic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Wang F; Department of Sports Medicine, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhong Y; Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, and Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhang X; Institute of Translational Medicine, Shanghai University, Shanghai, People's Republic of China.
  • Chin G; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, and Department of Orthopedic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Liu Q; Department of Sports Medicine, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhou W; Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, and Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Liu H; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, and Department of Orthopedic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Chen J; Department of Sports Medicine, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Ouyang H; Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, and Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Stem Cells Transl Med ; 11(5): 552-565, 2022 05 27.
Article in En | MEDLINE | ID: mdl-35511745
ABSTRACT
Mesenchymal stem cells (MSCs) have been widely used as functional components in tissue engineering. However, the immunogenicity and limited pro-angiogenic efficacy of MSCs greatly limited their pro-regenerative ability in allogenic treatment. Herein, utilizing a chemically defined cocktail in the culture system, including cytokines, small molecules, structural protein, and other essential components, we generated the immunoprivileged and pro-angiogenic cells (IACs) derived from human adipose tissues. Conventional adipose-derived MSCs (cADSCs) were used as a control in all the experiments. IACs show typical MSC properties with enhanced stemness capacity and a robust safety profile. IACs induce a significantly milder immune response of allogenic peripheral blood mononuclear cells in an H3K27me3-HLA axis-dependent manner. IACs, through superior paracrine effects, further promote nitric oxide production, anti-apoptotic ability, and the tube formation of human vein endothelial cells. Embedded in a photo-reactive hydrogel (Gel) termed as GelMA/HA-NB/LAP for tissue engineering treatment, IACs promote faster tissue regeneration in a xenogeneic full-thickness skin defect model, eliciting a milder immune response and enhanced blood vessel formation in IACs-treated defect areas. Together with its excellent pro-regenerative potential and robust safety, our findings suggest that IACs may be a promising candidate for clinically relevant stem cell and tissue engineering therapeutics.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endothelial Cells / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Humans Language: En Journal: Stem Cells Transl Med Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endothelial Cells / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Humans Language: En Journal: Stem Cells Transl Med Year: 2022 Type: Article